Correction to: Letter to the Editor: A Favorable Benefit –Risk Balance Maybe Expected with Replication-Defective Adenovirus-Mediated Interferon Gene Therapy for Cancer Treatment, by Qin Hum Gene Ther 2023;34(7-8):339–340; doi: 10.1089/hum.2023.028

Human Gene Therapy, Ahead of Print.
Source: Human Gene Therapy - Category: Genetics & Stem Cells Source Type: research